HomeCompareDSVSF vs JNJ

DSVSF vs JNJ: Dividend Comparison 2026

DSVSF yields 31.30% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DSVSF wins by $112.2K in total portfolio value
10 years
DSVSF
DSVSF
● Live price
31.30%
Share price
$6.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$142.6K
Annual income
$19,578.02
Full DSVSF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — DSVSF vs JNJ

📍 DSVSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDSVSFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DSVSF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DSVSF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DSVSF
Annual income on $10K today (after 15% tax)
$2,660.41/yr
After 10yr DRIP, annual income (after tax)
$16,641.32/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, DSVSF beats the other by $12,603.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DSVSF + JNJ for your $10,000?

DSVSF: 50%JNJ: 50%
100% JNJ50/50100% DSVSF
Portfolio after 10yr
$86.5K
Annual income
$12,163.95/yr
Blended yield
14.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DSVSF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
3.3
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DSVSF buys
0
JNJ buys
0
No recent congressional trades found for DSVSF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDSVSFJNJ
Forward yield31.30%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$142.6K$30.5K
Annual income after 10y$19,578.02$4,749.88
Total dividends collected$98.9K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: DSVSF vs JNJ ($10,000, DRIP)

YearDSVSF PortfolioDSVSF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,830$3,129.89$10,594$274.49+$3.2KDSVSF
2$18,843$4,045.42$11,294$360.69+$7.5KDSVSF
3$25,314$5,151.35$12,133$476.91+$13.2KDSVSF
4$33,553$6,467.48$13,156$635.42+$20.4KDSVSF
5$43,914$8,011.77$14,432$854.61+$29.5KDSVSF
6$56,787$9,799.65$16,056$1,162.76+$40.7KDSVSF
7$72,606$11,843.45$18,175$1,604.53+$54.4KDSVSF
8$91,840$14,151.90$21,009$2,252.68+$70.8KDSVSF
9$114,999$16,729.84$24,911$3,229.73+$90.1KDSVSF
10$142,627$19,578.02$30,458$4,749.88+$112.2KDSVSF

DSVSF vs JNJ: Complete Analysis 2026

DSVSFStock

Discovery Silver Corp., a mineral exploration company, engages in the exploration and development of polymetallic deposits. The company's flagship property is the Cordero silver project, which covers an area of approximately 35,000 hectares located in the Chihuahua state, Mexico. It also holds option agreement to purchase 100% interest in the Puerto Rico, La Kika, Minerva, Monclova, and Santa Rosa projects in Mexico. The company was formerly known as Discovery Metals Corp. and changed its name to Discovery Silver Corp. Discovery Silver Corp. was incorporated in 1986 and is headquartered in Toronto, Canada.

Full DSVSF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this DSVSF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DSVSF vs SCHDDSVSF vs JEPIDSVSF vs ODSVSF vs KODSVSF vs MAINDSVSF vs ABBVDSVSF vs MRKDSVSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.